Clinuvel Pharmaceuticals
CUV.AX
#8683
Rank
C$0.34 B
Marketcap
C$6.92
Share price
-1.40%
Change (1 day)
-33.25%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2026: C$46.09 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are C$64.99 Million. In 2026 the company made an earning of C$46.09 Million a decrease over its 2025 earnings that were of C$47.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026C$46.09 M-2.84%
2025C$47.44 M0.26%
2024C$47.32 M11.35%
2023C$42.49 M28.31%
2022C$33.12 M22.8%
2021C$26.97 M112.63%
2020C$12.68 M-28.73%
2019C$17.8 M32.79%
2018C$13.4 M75.41%
2017C$7.64 M-332.52%
2016-C$3.29 Million-70.68%
2015-C$11.22 Million53.78%
2014-C$7.3 Million-16.1%
2013-C$8.69 Million-37.92%
2012-C$14 Million-18.19%
2011-C$17.11 Million25.31%
2010-C$13.66 Million-21.53%
2009-C$17.41 Million-11.27%
2008-C$19.62 Million80.4%
2007-C$10.88 Million-2.46%
2006-C$11.15 Million-5.35%
2005-C$11.78 Million60.55%
2004-C$7.34 Million97.37%
2003-C$3.72 Million50.62%
2002-C$2.47 Million121.22%
2001-C$1.12 Million254.48%
2000-C$0.32 Million